secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001822479-23-000012
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q4 net loss $320M on $408M legal reserve; provides 2023 outlook of 5-9% growth
--------------------------------------------------------------------------------

- Q4 net revenues $252M (+4% YoY); net loss $320M ($1.14/share) vs net income $36M in Q4 2021.
- Q4 net loss includes $408M reserve for ethylene oxide claims settlement in Cook County, IL.
- Q4 adjusted EBITDA $130M (+4% YoY); adjusted EPS $0.25 (+$0.02).
- Closed $500M Term Loan B in February 2023.
- Full-year 2023 outlook: net revenues and adjusted EBITDA growth of 5% to 9%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247923000012/0001822479-23-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247923000012/shc-20230228.htm
  HTML page:      https://secwatch.observer/filing/0001822479-23-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer